Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations
Francesco Passamonti, Emanuele Nicastri, Alice Di Rocco, et al.
Hematological Oncology (2022) Vol. 41, Iss. 1, pp. 3-15
Open Access | Times Cited: 18

Showing 18 citing articles:

BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia
Annalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
The burden of COVID-19 death for different cancer types: a large population-based study
You Mo, Duncan Wei, Xiaozheng Chen, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Safe prescribing in cancer patients during the COVID‐19 pandemic and outcomes following restart of cancer care following SARS‐CoV‐2 infection: The COV‐SPOT initiative
Nathan Appanna, Rosie Mew, Sophie Williams, et al.
International Journal of Cancer (2025)
Closed Access
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
Serena Vita, Alessandra D’Abramo, Andrea Coppola, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma
Kenta Hayashino, Keisuke Seike, Kanako Fujiwara, et al.
International Journal of Hematology (2024) Vol. 119, Iss. 4, pp. 459-464
Open Access | Times Cited: 2
THE EXPEDIENCY OF INCLUDING AN INDIVIDUAL SCIENTIFIC WORK AS A MANDATORY COMPONENT IN THE EDUCATIONAL AND PROFESSIONAL PROGRAM OF MEDICINE
O. Ye. Akimov, A.V. Mishchenko, N.V. Solovyova, et al.
Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії (2024) Vol. 24, Iss. 1, pp. 168-172
Open Access | Times Cited: 2
Management of vaccinations in patients with non‐Hodgkin lymphoma
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1617-1634
Open Access | Times Cited: 2
Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
Wenjing Guo, Yizhou Zheng, Sizhou Feng
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
The unmet need for COVID-19 treatment in immunocompromised patients
Alessandra D’Abramo, Serena Vita, Emanuele Nicastri
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study
Haruka Shimazu, Daiki Wada, Shuhei Maruyama, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Current and future therapies for follicular lymphoma
Pier Luigi Zinzani, Javier Muñoz, Judith Trotman
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Outcomes of COVID‐19 in patients with lymphomas participating in registered clinical trials: A real‐world study from China in the Omicron outbreak era
Peng Sun, Hang Yang, Baitian Zhao, et al.
Cancer Medicine (2023) Vol. 12, Iss. 23, pp. 21148-21158
Open Access | Times Cited: 2
Efficacy of Combination of Antiviral Therapy With Neutralizing Monoclonal Antibodies for Recurrent Persistent SARS‐CoV‐2 Pneumonia in Patients With Lymphoma
Xiaoyan Gai, Xiaoyan Sun, Beibei Liu, et al.
BioMed Research International (2024) Vol. 2024, Iss. 1
Open Access
COVID-19 and Cancer Care: A Review and Practical Guide to Caring for Cancer Patients in the Era of COVID-19
Simon Claveau, Farhan Mahmood, Baraa Amir, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5330-5343
Open Access
Outcomes and Patterns of Evolution of Patients with Hematological Malignancies during the COVID-19 Pandemic: A Nationwide Study (2020–2022)
Rafael García Carretero, María Ordoñez-Garcia, Ruth Gil-Prieto, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5400-5400
Open Access
COVID-19 infection in children with blood cancer: A systematic review
Saad Alhumaid, Khalid Al Noaim, Anwar A. Almuslim, et al.
Annals of Hematology (2024)
Open Access
Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.
Giovanni Manfredi Assanto, Matteo Totaro, Poggiali Rebecca, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2023) Vol. 15, Iss. 1, pp. e2023061-e2023061
Open Access | Times Cited: 1
Blood cancer in children infected with COVID-19: A comprehensive systematic review
Saad Alhumaid, Khalid Al Noaim, Anwar A. Almuslim, et al.
Research Square (Research Square) (2023)
Open Access
Hematoloji ve COVID-19
Cenk Sunu, Tuba Hacıbekiroğlu
(2023), pp. 377-400
Open Access
Page 1

Scroll to top